However, due to the fact that conventional insulin assay has cross-reactivity with proinsulin, there is a debate as to whether hyperinsulinemia or hyperproinsulinemia exists in newly diagnosed T2DM [10]. The gene discussed is INS; the disease is hyperproinsulinemia.